BioSpace News Archive

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Sensorion a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has announced the results of resolutions presented at its General Assembly on May 20, 2020 and made them available on the dedicated section of its website.

AGC Biologics, a global Contract Development and Manufacturing Organization for Biopharmaceuticals, has announced its partnership with Takara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.

BD announced that it has priced its previously announced registered offerings of $1.5 billion of common stock, par value $1.00 per share, at a public offering price of $240.00 per share, and $1.5 billion of depositary shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B, par value $1.00 per share, at a public offering price of $50.00 per share.

The Duchenne muscular dystrophy testing market expects a surge in the growth rate across the forecast period of 2019-2029 mainly due to the rising awareness about the disease and the new methods to detect Duchenne muscular dystrophy at an early stage to enable quick recovery by providing timely treatment.

TMR Research has come up with a new research report that offers key insights and information about the global anti-snoring devices market.

The global CAR-T cell therapy market is set to chart stellar growth owing to an impressive CAGR between 2018 and 2028.

The global immunohistochemistry market is projected to expand at a healthy pace.

The indiscriminate use of mechanical ventilators for COVID-19 patients around the world has led to massive revenue earning for manufacturers in mechanical ventilators market.

The global Recombinant Human Endostatin market report is an-depth study of drivers, trends, and economic forecast.